Section Arrow
Quote
PRCT.NASDAQ
- PROCEPT BioRobotics Corp
Quotes are at least 15-min delayed:2025/10/24 01:33 EDT
Regular Hours
Last
 34.62
-0.48 (-1.37%)
Day High 
35.545 
Prev. Close
35.1 
1-M High
39.99 
Volume 
901.50K 
Bid
34.32
Ask
35.03
Day Low
34.3152 
Open
35 
1-M Low
32.1101 
Market Cap 
1.95B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 33.98 
20-SMA 34.79 
50-SMA 37.46 
52-W High 103.8099 
52-W Low 32.1101 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.54/-1.07
Enterprise Value
2.03B
Balance Sheet
Book Value Per Share
6.93
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
224.50M
Operating Revenue Per Share
2.09
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
QSIQuantum-Si2.2--0.000%-- 
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
PMIPicard Medical Inc13.2+0.03+0.23%-- 
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
Quotes are at least 15-min delayed：2025/10/24 01:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.